MP
REVBW icon

Mangrove Partners’s Revelation Biosciences Warrant REVBW Stock Holding History

Mangrove Partners’s Portfolio REVBW Stock Details REVBW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-131,980
Closed -$1.33M – 527
2021
Q3 		$1.33M Buy
131,980
+21,620
+20% +$13.1K 0.12% 275
2021
Q2 		$71K Buy
110,360
+15,260
+16% +$9.1K 0.01% 318
2021
Q1 		$49K Buy
+95,100
New +$88.9K ﹤0.01% 297

Other funds holding REVBW

OCAM
Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $351M AUM 21.82% 1-Year Est. Return
ICM
Ionic Capital Management New York $690M AUM 70.34% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
Polar Asset Management Partners
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
Capstone Investment Advisors
Capstone Investment Advisors New York $54B AUM 23.5% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Mangrove Partners's REVBW Position: Q4 2021 in Review

Mangrove Partners sold out of Revelation Biosciences Warrant (REVBW) in Q4 2021, closing a stake of 131,980 shares — an estimated $1.33M sold.

Mangrove Partners first reported a position in REVBW in Q1 2021 and held it in 3 quarters. The position peaked at $1.33M in Q3 2021. 20 funds tracked by Wall St. Rank hold REVBW as of Q4 2021.

  • Mangrove Partners reported no remaining Revelation Biosciences Warrant position as of Q4 2021 after selling out during the quarter.
  • Mangrove Partners sold 131,980 Revelation Biosciences Warrant shares in Q4 2021, an estimated $1.33M.
  • Mangrove Partners first reported a position in Revelation Biosciences Warrant in Q1 2021 and held it in 3 quarters.
  • Mangrove Partners's Revelation Biosciences Warrant position peaked at $1.33M in Q3 2021.
  • 20 funds tracked by Wall St. Rank held Revelation Biosciences Warrant as of Q4 2021.

Based on Mangrove Partners's 13F filing for Q4 2021, filed 14 Feb 2022.